Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor We are concerned that a JAMA Patient Page1 regarding statin therapy for hyperlipidemia sent the wrong message to patients. We found this piece to be unbalanced. The authors failed to mention anything about the unequivocal benefit of statins in secondary prevention settings, but devoted a full paragraph to adverse effects.
In addition, at the end of the adverse effects paragraph, the last 2 sentences of the Patient Page discussed the controversial aspects of primary prevention: “a 2010 analysis combined the results of 11 studies and found that taking statins did not lower the death rate for people who did not have heart disease. If your physician recommends taking a statin, talk to him or her about the risks and benefits for your individual situation.”
McEvoy JW, Blumenthal RS, Blaha MJ. Statin Therapy for Hyperlipidemia. JAMA. 2013;310(11):1184-1185. doi:10.1001/jama.2013.276734